Biotech

All Articles

Oncternal stock drains 60% among unemployments, test discontinuations

.Cancer firm Oncternal Therapies is folding all its scientific trials and laying off personnel, turn...

Roche is keeping out hopes that its injectable obesity possibility could at some point display 25% weight reduction in late-stage test

.Roche is storing out chances that its injectable obesity possibility might inevitably display 25% f...

Novo Nordisk barrages 'impressive' weight management result for dual-acting dental medicine in very early trial

.Novo Nordisk has raised the lid on a period 1 test of its own dental amylin as well as GLP-1 recept...

AbbVie files a claim against BeiGene over blood cancer drug secret method

.Only a few brief weeks after succeeding an FDA Fast Track tag for its own investigational BTK degra...

Lilly delivers one-two blow along with 2nd tranche of positive data on weekly insulin applicant

.Not long after a positive information decrease for Eli Lilly's efsitora alfa, the Indianapolis-base...

BridgeBio cuts genetics treatment budget plan as medical data let down

.BridgeBio Pharma is lowering its gene treatment spending plan and pulling back from the modality af...

GSK relinquishes HSV vaccine wishes after stage 2 fail, ceding ethnicity to Moderna, BioNTech

.GSK's attempt to develop the first injection for genital herpes simplex virus (HSV) has finished in...

GSK's long-acting breathing problem drug halved assaults in period 3

.GSK's long-acting bronchial asthma procedure has actually been actually shown to cut in half the am...

AstraZeneca, Daiichi unload Dato-DXd's general survival fail

.AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has stopped working t...

Roivant introduces brand-new 'vant' to evolve Bayer high blood pressure med

.Matt Gline is back with a brand-new 'vant' firm, after the Roivant Sciences CEO paid for Bayer $14 ...